Many people with Alzheimer’s disease suffer from psychotic episodes or agitation and aggression. Meridien Research is conducting a study of an investigational medication designed to aid with these symptoms. To qualify, individuals must:
- Be 50+ years of age
- Have Alzheimer’s disease
- Be experiencing psychotic episodes (visual and/or auditory hallucinations, and/or delusions) or aggression or agitation
- Have a study partner knows the individual well
Eligible participants will receive study-related care, monitoring and study drug or placebo. Reimbursement for travel will be available to participants and their caregivers who qualify. All studies administered by a board certified physician. For more information, please call 727-347-8839 or complete the form below.